HeartFlow Stock
Medical Technology Company
Sign up today and learn more about HeartFlow Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About HeartFlow Stock
HeartFlow is a medical technology company that provides non-invasive coronary artery disease detection services. The company's main product is HeartFlow FFRÂ Analysis, which aims to help a physician evaluate whether a patient has significant coronary artery disease. HeartFlow FFRCT Analysis uses a CT scan ordered by a physician to generate a 3D model of the patient's coronary arteries. The analysis aims to calculate the amount of blockage in the arteries and the limited blood flow. The HeartFlow FFRCT Analysis is commercially available in the United States, Canada, Europe, and Japan.Â
Christopher K. Zarins and Charles Anthony Taylor founded Cardiovascular Simulation in 2007 which became HeartFlow in May 2009. The company is headquartered in Redwood City, California. Notable investors include Panorama Point Partners, Capricorn Investment Group, and Baillie Gifford.
Investors
Wellington Management
Swiggy, Scopely, Cityblock Health, Attentive, HeartFlow, Skims, Urban Company, Greenlight, Guild Education, Omada Health
Capricorn Investment Group
HeartFlow, Aspiration, QuantumScape, Innovium, Diamond Foundry, Kinestral Technologies, Twelve
Rancilio Cube
Emergent Medical Partners
Funding History
July 2009 | $2.0M |
---|---|
August 2010 | $6.9M |
August 2010 | $10.1M |
December 2011 | $105M |
January 2015 | $111M |
November 2017 | $305M |
March 2023 | $41.0M |
March 2023 | $175M |
Management
Chief Executive Officer
John Farquhar
Chief Scientific Officer
Charles Anthony Taylor
Press
dicardiology - Feb, 19 2024
HeartFlow Achieves Landmark Milestone of 250000 Patients Assessed for Coronary Artery Disease (CAD) with FFRCT ...globenewswire - Feb, 3 2024
HeartFlow Announces New Reimbursement Code and Increased Payment for FFRCTmpo-mag - Oct, 7 2023
Studies Validate HeartFlow’s CCTA-Based Coronary Care Solutionsdlvr - Apr, 12 2023
Precision Heart Care Company HeartFlow Raises $215 Million